vs

Side-by-side financial comparison of First Watch Restaurant Group, Inc. (FWRG) and NEOGEN CORP (NEOG). Click either name above to swap in a different company.

First Watch Restaurant Group, Inc. is the larger business by last-quarter revenue ($316.4M vs $224.7M, roughly 1.4× NEOGEN CORP). On growth, First Watch Restaurant Group, Inc. posted the faster year-over-year revenue change (20.2% vs -2.8%). NEOGEN CORP produced more free cash flow last quarter ($7.8M vs $-18.3M). Over the past eight quarters, First Watch Restaurant Group, Inc.'s revenue compounded faster (14.2% CAGR vs -0.9%).

Ruby Tuesday Inc. is an American multinational foodservice retailer that owns, operates, and franchises Ruby Tuesday restaurants. The concept was started in 1972 by Samuel E. (Sandy) Beall III.

Neogen Corporation is an international food safety company that provides test kits and relevant products to detect dangerous substances in food. The company was founded in 1982 and is based in Lansing, Michigan. The company serves a wide range of countries including Canada, United States, the United Kingdom, parts of Europe, Mexico and Brazil, India, and China, among others. The company operates a product line of over 100 drug detection test kits worldwide for the detection of about 300 abuse...

FWRG vs NEOG — Head-to-Head

Bigger by revenue
FWRG
FWRG
1.4× larger
FWRG
$316.4M
$224.7M
NEOG
Growing faster (revenue YoY)
FWRG
FWRG
+23.0% gap
FWRG
20.2%
-2.8%
NEOG
More free cash flow
NEOG
NEOG
$26.1M more FCF
NEOG
$7.8M
$-18.3M
FWRG
Faster 2-yr revenue CAGR
FWRG
FWRG
Annualised
FWRG
14.2%
-0.9%
NEOG

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
FWRG
FWRG
NEOG
NEOG
Revenue
$316.4M
$224.7M
Net Profit
$-15.9M
Gross Margin
47.5%
Operating Margin
2.9%
-2.4%
Net Margin
-7.1%
Revenue YoY
20.2%
-2.8%
Net Profit YoY
96.5%
EPS (diluted)
$0.24
$-0.07

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FWRG
FWRG
NEOG
NEOG
Q4 25
$316.4M
$224.7M
Q3 25
$316.0M
$209.2M
Q2 25
$307.9M
$225.4M
Q1 25
$282.2M
$221.0M
Q4 24
$263.3M
$231.3M
Q3 24
$251.6M
$217.0M
Q2 24
$258.6M
$236.8M
Q1 24
$242.4M
$228.8M
Net Profit
FWRG
FWRG
NEOG
NEOG
Q4 25
$-15.9M
Q3 25
$3.0M
$36.3M
Q2 25
$2.1M
$-612.3M
Q1 25
$-829.0K
$-10.9M
Q4 24
$-456.3M
Q3 24
$2.1M
$-12.6M
Q2 24
$8.9M
$-5.4M
Q1 24
$7.2M
$-2.0M
Gross Margin
FWRG
FWRG
NEOG
NEOG
Q4 25
47.5%
Q3 25
45.4%
Q2 25
41.2%
Q1 25
49.9%
Q4 24
49.0%
Q3 24
48.4%
Q2 24
47.9%
Q1 24
51.1%
Operating Margin
FWRG
FWRG
NEOG
NEOG
Q4 25
2.9%
-2.4%
Q3 25
3.2%
-7.7%
Q2 25
2.4%
-271.1%
Q1 25
0.4%
2.4%
Q4 24
1.5%
-197.8%
Q3 24
2.5%
1.0%
Q2 24
6.4%
5.5%
Q1 24
5.1%
5.3%
Net Margin
FWRG
FWRG
NEOG
NEOG
Q4 25
-7.1%
Q3 25
0.9%
17.4%
Q2 25
0.7%
-271.6%
Q1 25
-0.3%
-4.9%
Q4 24
-197.3%
Q3 24
0.8%
-5.8%
Q2 24
3.4%
-2.3%
Q1 24
3.0%
-0.9%
EPS (diluted)
FWRG
FWRG
NEOG
NEOG
Q4 25
$0.24
$-0.07
Q3 25
$0.05
$0.17
Q2 25
$0.03
$-2.82
Q1 25
$-0.01
$-0.05
Q4 24
$0.01
$-2.10
Q3 24
$0.03
$-0.06
Q2 24
$0.14
$-0.02
Q1 24
$0.12
$-0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FWRG
FWRG
NEOG
NEOG
Cash + ST InvestmentsLiquidity on hand
$21.2M
$145.3M
Total DebtLower is stronger
$269.1M
Stockholders' EquityBook value
$626.3M
$2.1B
Total Assets
$1.7B
$3.4B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FWRG
FWRG
NEOG
NEOG
Q4 25
$21.2M
$145.3M
Q3 25
$20.7M
$138.9M
Q2 25
$19.2M
$129.0M
Q1 25
$18.6M
$127.7M
Q4 24
$33.3M
$140.2M
Q3 24
$51.1M
$120.5M
Q2 24
$45.1M
$170.9M
Q1 24
$43.2M
$168.4M
Total Debt
FWRG
FWRG
NEOG
NEOG
Q4 25
$269.1M
Q3 25
$251.0M
Q2 25
$250.0M
Q1 25
$191.5M
Q4 24
$189.0M
Q3 24
$189.7M
Q2 24
$192.1M
Q1 24
$122.7M
Stockholders' Equity
FWRG
FWRG
NEOG
NEOG
Q4 25
$626.3M
$2.1B
Q3 25
$607.3M
$2.1B
Q2 25
$601.3M
$2.1B
Q1 25
$596.3M
$2.7B
Q4 24
$595.4M
$2.7B
Q3 24
$589.1M
$3.1B
Q2 24
$585.8M
$3.1B
Q1 24
$574.4M
$3.1B
Total Assets
FWRG
FWRG
NEOG
NEOG
Q4 25
$1.7B
$3.4B
Q3 25
$1.7B
$3.4B
Q2 25
$1.7B
$3.4B
Q1 25
$1.5B
$4.0B
Q4 24
$1.5B
$4.1B
Q3 24
$1.5B
$4.5B
Q2 24
$1.4B
$4.5B
Q1 24
$1.3B
$4.6B
Debt / Equity
FWRG
FWRG
NEOG
NEOG
Q4 25
0.43×
Q3 25
0.41×
Q2 25
0.42×
Q1 25
0.32×
Q4 24
0.32×
Q3 24
0.32×
Q2 24
0.33×
Q1 24
0.21×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FWRG
FWRG
NEOG
NEOG
Operating Cash FlowLast quarter
$18.5M
$19.4M
Free Cash FlowOCF − Capex
$-18.3M
$7.8M
FCF MarginFCF / Revenue
-5.8%
3.5%
Capex IntensityCapex / Revenue
11.6%
5.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-31.0M
$-18.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FWRG
FWRG
NEOG
NEOG
Q4 25
$18.5M
$19.4M
Q3 25
$47.9M
$10.9M
Q2 25
$39.4M
$16.4M
Q1 25
$20.1M
$19.5M
Q4 24
$22.9M
$40.3M
Q3 24
$35.9M
$-17.9M
Q2 24
$31.9M
$26.7M
Q1 24
$25.0M
$-30.2M
Free Cash Flow
FWRG
FWRG
NEOG
NEOG
Q4 25
$-18.3M
$7.8M
Q3 25
$5.5M
$-13.1M
Q2 25
$-1.7M
$349.0K
Q1 25
$-16.4M
$-13.4M
Q4 24
$-17.7M
$23.1M
Q3 24
$6.8M
$-56.3M
Q2 24
$2.3M
$2.5M
Q1 24
$-3.6M
$-62.3M
FCF Margin
FWRG
FWRG
NEOG
NEOG
Q4 25
-5.8%
3.5%
Q3 25
1.7%
-6.3%
Q2 25
-0.5%
0.2%
Q1 25
-5.8%
-6.1%
Q4 24
-6.7%
10.0%
Q3 24
2.7%
-26.0%
Q2 24
0.9%
1.1%
Q1 24
-1.5%
-27.2%
Capex Intensity
FWRG
FWRG
NEOG
NEOG
Q4 25
11.6%
5.2%
Q3 25
13.4%
11.5%
Q2 25
13.4%
7.1%
Q1 25
13.0%
14.9%
Q4 24
15.4%
7.4%
Q3 24
11.6%
17.7%
Q2 24
11.5%
10.2%
Q1 24
11.8%
14.0%
Cash Conversion
FWRG
FWRG
NEOG
NEOG
Q4 25
Q3 25
16.01×
0.30×
Q2 25
18.72×
Q1 25
Q4 24
Q3 24
16.98×
Q2 24
3.59×
Q1 24
3.46×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FWRG
FWRG

In Restaurant Dining Sales$254.1M80%
Third Party Delivery Sales$38.6M12%
Take Out Sales$21.3M7%
Royalty And System Fund Contributions$2.3M1%

NEOG
NEOG

Other$109.2M49%
Bacterial And General Sanitation$44.9M20%
Services$25.7M11%
Natural Toxins And Allergens$20.4M9%
Animal Care$8.9M4%
Genomics Services$6.3M3%
Biosecurity Products$4.6M2%
Life Sciences$1.4M1%

Related Comparisons